Christopher S. Boerner, Ph.D.

    1 board
    Healthcare
    As of 8/31/2026

    0.29

    Boardminder Score™

    Bottom 16% of 4,262 directors

    Lower scoreHigher score

    3.7

    Avg Tenure (yrs)

    Shorter tenure than 73% of directors

    ShorterLonger

    Total Compensation

    Board Seats Breakdown
    Bristol-Myers Squibb Company
    BMY
    F500 #96
    Board Chair & Chief Executive Officer
    Healthcare
    Seat Score
    0.29
    Tenure
    3.7 yrs
    Compensation
    Excess Return
    -108.5%